作者: Edwin A. Collier , Minh Nguyen
DOI:
关键词:
摘要: The present invention is directed to L-proline and citric acid co-crystals of (2S,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4- methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, pharmaceutical compositions containing said their use in the treatment glucose-related disorders such as Type 2 diabetes mellitus Syndrome X.